dc.contributor.author | Van Buynder, P | |
dc.date.accessioned | 2020-09-24T22:29:44Z | |
dc.date.available | 2020-09-24T22:29:44Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 1443-430X | |
dc.identifier.uri | http://hdl.handle.net/10072/397877 | |
dc.description.abstract | Disease due to pneumococcus (Streptococcus pneumoniae) remains a major source of illness in older people. Conjugated pneumococcal vaccines are used extensively in national paediatric programs, whereas a 23-valent polysaccharide vaccine is mainly used in older people and high-risk groups. Data from the Netherlands have led to licensing of a conjugated pneumococcal vaccine for older people in Australia. This review examines current recommendations on pneumococcal vaccines. | |
dc.description.peerreviewed | Yes | |
dc.publisher | Medicine Today Pty. Ltd. | |
dc.publisher.uri | https://medicinetoday.com.au/2019/february/feature-article/reducing-pneumococcal-risk-people-aged-65-years-and-over | |
dc.relation.ispartofpagefrom | 11 | |
dc.relation.ispartofpageto | 14 | |
dc.relation.ispartofissue | 2 Suppl | |
dc.relation.ispartofjournal | Medicine Today | |
dc.relation.ispartofvolume | 20 | |
dc.subject.fieldofresearch | Biomedical and clinical sciences | |
dc.subject.fieldofresearch | Clinical sciences | |
dc.subject.fieldofresearchcode | 32 | |
dc.subject.fieldofresearchcode | 3202 | |
dc.title | Reducing pneumococcal risk in people aged 65 years and over | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dcterms.bibliographicCitation | Van Buynder, P, Reducing pneumococcal risk in people aged 65 years and over, Medicine Today, 2019, 20 (2 Suppl), pp. 11-14 | |
dc.date.updated | 2020-09-24T00:55:13Z | |
dc.description.version | Version of Record (VoR) | |
gro.rights.copyright | © 2019 Medicine Today Pty. Ltd.. Reproduced in accordance with the copyright policy of the publisher. Use hypertext link for access to the publisher's website. | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Van Buynder, Paul G. | |